• Privacy Policy
  • Terms & Conditions
Top Stocks Insider
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Top Stocks Insider
No Result
View All Result
Home Investing

One Step Forward? The Trump Administration Considers Rescheduling Marijuana

by
August 12, 2025
in Investing
0
One Step Forward? The Trump Administration Considers Rescheduling Marijuana
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Matthew Cavedon

If you blinked, you probably missed it: In the same press conference where he announced a federal takeover of DC policing, President Trump also mentioned that he is considering rescheduling marijuana. This small but positive move would build on efforts started under President Biden.

For half a century now, marijuana has been classified under Schedule I of the Controlled Substances Act. That makes it a federal crime to manufacture, distribute, or dispense cannabis. (Separately, it is also a federal crime to possess it.) Theoretically, falling under Section I is supposed to be based on a substance having “no currently accepted medical use in treatment” and “a lack of accepted safety for use … under medical supervision.” In reality, the absolute federal prohibition of marijuana is based not on medicine and science but on political judgments about morality and risks.

Even though state-level legalizations of marijuana and federal decisions to limit enforcement efforts have changed much of the legal landscape for cannabis, its Schedule I classification still has practical effects. This places high barriers on researchers seeking to study marijuana’s effects and blocks cannabis-related businesses from claiming federal income-tax deductions.

The president is considering reclassifying marijuana under Schedule III. While this would not legalize the drug, it would recognize what is apparent to 47 states, three territories, and DC—marijuana “has a currently accepted medical use in treatment.” In addition to easing research and tax burdens, reclassification could help destigmatize cannabis. It could also reignite long-stalled efforts in Congress to pass the SAFER Banking Act, which would let banks and other financial companies work with marijuana-related businesses. 

Further, as a matter of policing, acknowledging medical marijuana’s existence could reduce the probable cause associated with the drug’s odor. That might mean fewer marijuana-related traffic stops, body searches, and arrests, depending on the significance the courts give the reclassification.

President Trump’s press conference announced big steps backward from sane policing and toward a dangerous militarized model. While it may be little consolation, at least he also mentioned the possibility of a minor de-escalation in the War on Drugs. The better path forward would be respecting the proper role of the federal government by ending the failed prohibition regime altogether, as well as legalizing drug use in the states. Society can tolerate and reasonably regulate marijuana as a minor vice like alcohol. Society should also realize that criminalizing even harmful drug addiction is a blunt instrument for what is ultimately a medical and moral concern.

Previous Post

The Meaning of Coercion in Hayekian Philosophy

Next Post

Why Trump’s Tariffs Make No Sense and a Counterproduct to MAGA

Next Post

Why Trump’s Tariffs Make No Sense and a Counterproduct to MAGA

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Disclaimer: TopStocksInsider.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 TopStocksInsider. All Rights Reserved.

    No Result
    View All Result
    • News
    • Economy
    • Editor’s Pick
    • Investing
    • Stock

    Copyright © 2024 TopStocksInsider. All Rights Reserved.